Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Daniel Zingg; Jinhyuk Bhin; Julia Yemelyanenko; Sjors M Kas; Frank Rolfs; Catrin Lutz; Jessica K Lee; Sjoerd Klarenbeek; Ian M Silverman; Stefano Annunziato; Chang S Chan; Sander R Piersma; Timo Eijkman; Madelon Badoux; Ewa Gogola; Bjørn Siteur; Justin Sprengers; Bim de Klein; Richard R de Goeij-de Haas; Gregory M Riedlinger; Hua Ke; Russell Madison; Anne Paulien Drenth; Eline van der Burg; Eva Schut; Linda Henneman; Martine H van Miltenburg; Natalie Proost; Huiling Zhen; Ellen Wientjens; Roebi de Bruijn; Julian R de Ruiter; Ute Boon; Renske de Korte-Grimmerink; Bastiaan van Gerwen; Luis Féliz; Ghassan K Abou-Alfa; Jeffrey S Ross; Marieke van de Ven; Sven Rottenberg; Edwin Cuppen; Anne Vaslin Chessex; Siraj M Ali; Timothy C Burn; Connie R Jimenez; Shridar Ganesan; Lodewyk F A Wessels; Jos Jonkers

doi:10.1038/s41586-022-05287-8

Publisher Correction: Truncated FGFR2 is a clinically actionable oncogene in multiple cancers

Nature. 2022 Sep;609(7929):E13. doi: 10.1038/s41586-022-05287-8.

Authors

Daniel Zingg^#^{1

2}, Jinhyuk Bhin^#^{1

2

3}, Julia Yemelyanenko^#^{1

2}, Sjors M Kas^#^{1

2}, Frank Rolfs^{1

2

4}, Catrin Lutz^{1

2}, Jessica K Lee⁵, Sjoerd Klarenbeek⁶, Ian M Silverman⁷, Stefano Annunziato^{1

2}, Chang S Chan^{8

9}, Sander R Piersma⁴, Timo Eijkman^{1

2}, Madelon Badoux^{1

2}, Ewa Gogola^{1

2}, Bjørn Siteur¹⁰, Justin Sprengers¹⁰, Bim de Klein^{1

2}, Richard R de Goeij-de Haas⁴, Gregory M Riedlinger^{9

11}, Hua Ke^{8

9}, Russell Madison⁵, Anne Paulien Drenth^{1

2}, Eline van der Burg^{1

2}, Eva Schut^{1

2}, Linda Henneman^{1

2

10}, Martine H van Miltenburg^{1

2}, Natalie Proost¹⁰, Huiling Zhen¹², Ellen Wientjens^{1

2}, Roebi de Bruijn^{1

2

3}, Julian R de Ruiter^{1

2

3}, Ute Boon^{1

2}, Renske de Korte-Grimmerink¹⁰, Bastiaan van Gerwen¹⁰, Luis Féliz¹³, Ghassan K Abou-Alfa^{14

15}, Jeffrey S Ross^{5

16}, Marieke van de Ven¹⁰, Sven Rottenberg^{1

17

18}, Edwin Cuppen^{2

19

20}, Anne Vaslin Chessex²¹, Siraj M Ali⁵, Timothy C Burn⁷, Connie R Jimenez⁴, Shridar Ganesan^{22

23}, Lodewyk F A Wessels^{24

25}, Jos Jonkers^{26

27}

Affiliations

¹ Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
² Oncode Institute, Utrecht, The Netherlands.
³ Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁴ OncoProteomics Laboratory, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
⁵ Foundation Medicine, Cambridge, MA, USA.
⁶ Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
⁷ Incyte Research Institute, Wilmington, DE, USA.
⁸ Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
⁹ Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA.
¹⁰ Mouse Clinic for Cancer and Aging, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹¹ Department of Pathology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
¹² Incyte, Wilmington, DE, USA.
¹³ Incyte Biosciences International, Morges, Switzerland.
¹⁴ Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
¹⁵ Department of Medicine, Weill Medical College at Cornell University, New York, NY, USA.
¹⁶ Upstate University Hospital, Upstate Medical University, Syracuse, NY, USA.
¹⁷ Institute of Animal Pathology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
¹⁸ Bern Center for Precision Medicine, University of Bern, Bern, Switzerland.
¹⁹ Hartwig Medical Foundation, Amsterdam, The Netherlands.
²⁰ Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
²¹ Debiopharm International, Lausanne, Switzerland.
²² Department of Medicine, Division of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA. ganesash@cinj.rutgers.edu.
²³ Department of Medicine and Pharmacology, Rutgers University, Piscataway, NJ, USA. ganesash@cinj.rutgers.edu.
²⁴ Oncode Institute, Utrecht, The Netherlands. l.wessels@nki.nl.
²⁵ Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands. l.wessels@nki.nl.
²⁶ Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands. j.jonkers@nki.nl.
²⁷ Oncode Institute, Utrecht, The Netherlands. j.jonkers@nki.nl.

^# Contributed equally.

No abstract available

Publication types

Published Erratum